AN 721
Alternative Names: AN-721; NSD-721Latest Information Update: 28 Jan 2018
At a glance
- Originator NeuroSearch
- Developer Aniona; Saniona
- Class Analgesics; Anxiolytics
- Mechanism of Action GABA A alpha 2 receptor modulators; GABA A alpha 3 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Inflammatory pain; Neuropathic pain; Pain
- Discontinued Anxiety disorders
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for preclinical development in Inflammatory-pain in Denmark
- 28 Jan 2018 No recent reports of development identified for preclinical development in Neuropathic-pain in Denmark
- 04 Nov 2017 No recent reports of development identified for phase-I development in Pain(In volunteers) in Denmark